263 related articles for article (PubMed ID: 18555127)
1. Postrenal transplant hemolytic uremic syndrome/thrombotic microangiopathy: Ahmedabad experience.
Goplani KR; Vanikar AV; Shah PR; Gumber M; Feroz A; Patel HV; Kasat P; Falodia J; Saboo D; Kaswaan K; Geerish MS; Pandya T; Trivedi HL
Transplant Proc; 2008 May; 40(4):1114-6. PubMed ID: 18555127
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
Bren A; Pajek J; Grego K; Buturovic J; Ponikvar R; Lindic J; Knap B; Vizjak A; Ferluga D; Kandus A
Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
[TBL] [Abstract][Full Text] [Related]
4. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.
Schwimmer J; Nadasdy TA; Spitalnik PF; Kaplan KL; Zand MS
Am J Kidney Dis; 2003 Feb; 41(2):471-9. PubMed ID: 12552512
[TBL] [Abstract][Full Text] [Related]
5. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathy after kidney transplantation.
Ponticelli C; Banfi G
Transpl Int; 2006 Oct; 19(10):789-94. PubMed ID: 16961769
[TBL] [Abstract][Full Text] [Related]
7. Posttransplantation calcineurin inhibitor-induced hemolytic uremic syndrome: single-center experience.
Said T; Al-Otaibi T; Al-Wahaib S; Francis I; Nair MP; Halim MA; El-Sayed A; Nampoory MR
Transplant Proc; 2010 Apr; 42(3):814-6. PubMed ID: 20430179
[TBL] [Abstract][Full Text] [Related]
8. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
[TBL] [Abstract][Full Text] [Related]
9. [Hemolytic-uremic syndrome following kidney transplantation: prognostic factors].
Candinas D; Keusch G; Schlumpf R; Burger HR; Gmür J; Largiadèr F
Schweiz Med Wochenschr; 1994 Oct; 124(41):1789-99. PubMed ID: 7973505
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
11. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
[TBL] [Abstract][Full Text] [Related]
12. [Thrombotic microangiopathy after kidney transplantation].
Basić-Jukić N; Jurić I; Brunetta-Gavranić B; Kes P; Bubić-Filipi L; Glavas-Boras S
Acta Med Croatica; 2008; 62 Suppl 1():93-6. PubMed ID: 18578340
[TBL] [Abstract][Full Text] [Related]
13. Graft failure due to hemolytic uremic syndrome recurrence.
Iaria G; Iorio B; Anselmo A; De Luca L; Tariciotti L; Ielpo B; Muzi F; Lucchesi C; D'Andria D; Orlando G; Del Poeta G; Poggi E; Piazza A; Tisone G
Transplant Proc; 2006 May; 38(4):1020-1. PubMed ID: 16757250
[TBL] [Abstract][Full Text] [Related]
14. Causes of acute thrombotic microangiopathy in patients receiving kidney transplantation.
Jumani A; Hala K; Tahir S; Al-Ghamdi G; Al-Flaiw A; Hejaili F; Qureshi J; Raza H; Ghalib M; Khader AA
Exp Clin Transplant; 2004 Dec; 2(2):268-72. PubMed ID: 15859940
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome.
Zimmerhackl LB; Besbas N; Jungraithmayr T; van de Kar N; Karch H; Karpman D; Landau D; Loirat C; Proesmans W; Prüfer F; Rizzoni G; Taylor MC;
Semin Thromb Hemost; 2006 Mar; 32(2):113-20. PubMed ID: 16575686
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study.
Zhang W; Shi H; Ren H; Shen PY; Pan XX; Li X; Chen YX; Xu YW; Chen XN; Zhu P; Chen N
Nephron Clin Pract; 2009; 112(3):c177-83. PubMed ID: 19439988
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitor-free immunosuppression in renal allograft recipients with thrombotic microangiopathy/hemolytic uremic syndrome.
Oyen O; Strøm EH; Midtvedt K; Bentdal O; Hartmann A; Bergan S; Pfeffer P; Brekke IB
Am J Transplant; 2006 Feb; 6(2):412-8. PubMed ID: 16426329
[TBL] [Abstract][Full Text] [Related]
18. [Thrombotic microangiopathy in adults].
Barrientos GJ; Michelangelo H
Medicina (B Aires); 2006; 66(4):289-95. PubMed ID: 16977962
[TBL] [Abstract][Full Text] [Related]
19. Renal transplantation in 20 children with hemolytic-uremic syndrome.
Eijgenraam FJ; Donckerwolcke RA; Monnens LA; Proesmans W; Wolff ED; van Damme B
Clin Nephrol; 1990 Feb; 33(2):87-93. PubMed ID: 2311309
[TBL] [Abstract][Full Text] [Related]
20. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.
Nishida T; Hamaguchi M; Hirabayashi N; Haneda M; Terakura S; Atsuta Y; Imagama S; Kanie T; Murata M; Taji H; Suzuki R; Morishita Y; Kodera Y
Bone Marrow Transplant; 2004 Jun; 33(11):1143-50. PubMed ID: 15077133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
